Nano-X Imaging Ltd.
Sector: X-Ray Apparatus & Tubes & Related Irradiation ApparatusIndustry: Medical - DevicesCountry: ILExchange: Nasdaq
DilutionScan read 22 of Nano-X Imaging Ltd.'s SEC filings and found 4 warrant series, 1 ATM program, 1 shelf registration and 2 completed offerings on file for NNOX. The latest dilution event on file is an offering on Aug 7, 2026. Analysis updated Oct 4, 2026.
Signal8 Summary
NNOX
Going-concern warning and tight cash runway
Snapshot
Nano-X is a medical imaging company in severe financial distress. It generated $13.0M in revenue in FY 2025, up 15.4% from the prior year, but lost $75.0M in net income. The core hardware business has negative gross margins, meaning the company loses money on every unit it sells, while heavy R&D spending of $19.2M (148% of revenue) drives the headline losses.
What's Happening Right Now
- : A class action lawsuit was filed against Nano-X for alleged securities fraud violations related to disclosures between March 2025 and April 2026.
- : An analyst downgraded the stock to sell, citing a shift from growth narrative to survival mode due to persistent cash burn and execution risks.
- : Nano-X reported Q1 2026 revenue of $4.3M but widened its net loss to $14.3M, withdrew its 2026 guidance, and issued a severe going-concern warning stating current cash is insufficient for the next 12 months.
